URGNUROGEN PHARMA LTD
CUSIP M96088105 · common stock
3 tracked investors held UROGEN PHARMA LTD (URGN) at the end of Q3 2026, worth $19.1M in total. The largest holder was Adar1 Capital Management, with 0.6% of its portfolio.
Holders · Q3 2026
3
New holders
0
Value held
$19.1M
Quarter-end price (est.)
$40.63
Investors holding URGN · Q3 2026
| Investor | Weight | Shares | Value | Change |
|---|---|---|---|---|
| Adar1 Capital Management ADAR1 Capital Management, LLC | 0.64% | 369,785 | $15M | ADD+46.5% |
| Cathie Wood ARK Investment Management LLC | 0.01% | 54,250 | $2.2M | REDUCE-46.6% |
| Polen Capital Management Polen Capital Management LLC | 0.02% | 46,801 | $1.9M | ADD+58.0% |